Author: michelle.abboud
Women’s health company awarded 2022 Tell Award
The MSD Merck spin-off is the third win for Lucerne in the past five years Canton Lucerne – The women’s health-focused pharma company, Organon, has been awarded the 2022 Tell Award for its success and contribution as an innovative company in Switzerland. This marks the third Tell Award win for a Lucerne-based company in the […]
December 13, 2022
Global oncology company from Lucerne expands in North America
The Swiss oncology company opens its first office in Canada Canton Lucerne – The global oncology company is expanding into Canada, making its innovative cancer therapy available throughout its new location. Novocure is a commercial-stage oncology company dedicated to the advancement of TTF therapy (Tumor Treating Fields) for patients with solid tumors. The company pioneered […]
November 15, 2022
Geistlich Pharma expands in Switzerland and acquires US-based Lynch Biologics
International Swiss medtech continues to grow its global footprint Canton Lucerne – Gestlich Pharma, the world market leader in regenerative dentistry, has acquired the Tennessee-based US medtech company: Lynch Biologics. Geistlich Pharma and Lynch Biologics share a mission to advance new regenerative technologies in dentistry. The aim is to provide even better support for the […]
October 27, 2022
Personalized health start-up Impli Limited brings its implantable sensor technology to Switzerland!
Lucerne – Impli, the personalized health start-up specializing in developing implantable sensors the size of a grain of rice, has chosen Technopark Lucerne to expand in continental Europe. Impli develops implantable technologies. Its first product, ImpliCaspian, was the first subdermal implant globally to be released. It is scanned using the Impli mobile application with NFC […]
April 25, 2022
Authorized for use in the USA: Geistlich Pharma’s collagen membrane
Canton Lucerne / Canton Zurich – The Geistlich Nexo-Gide, the collagen membrane developed by Swiss-based regenerative medical device company, Geistlich Pharma, has obtained clearance from the US Food and Drug Administration (FDA). The Nexo-Gide supports healing processes for tendon and ligament injuries, increasing the probability for successful surgical procedures for severe tendon and ligament injuries. […]
November 4, 2021
Altoida: years ahead in Alzheimer’s disease identification
Canton Lucerne – “Understanding your brain health should be simple,” says Altoida, a US-based biomedical startup with operations in Lucerne, Switzerland. Altoida, a Texas-based precision neurology startup, is building the digital engine to power early Alzheimer’s disease identification and personalized brain analysis. Its medical device has the approval of both US and European medical authorities. […]
August 6, 2021
Bio-pharmaceutical giant, Merck & Co. Inc. (MSD) maintains strong roots in Switzerland and continues to expand and grow in both Lucerne and Zurich
Canton Lucerne – With $48B in global Revenue (2020), Merck & Co., Inc. (a.k.a. MSD Merck Sharpe & Dohme) is a world-class, research-intensive bio-pharmaceutical company. Founded over 125 years ago in the United States, MSD is present in 140 countries with 74,000 employees as of 2020. MSD’s Swiss Branch opened in 1963 and through […]
July 22, 2021
Improving elderly care at Lucerne’s iHomeLab with “iSens light”
Canton Lucerne – iSens light is a commercially available sensor detecting irregularities in an elderly person’s movement patterns at home. If irregularities are observed, a caretaker is alerted! The iHomeLab, based in Lucerne, Switzerland, has produced the iSens light, a sensor placed near the bed of a person in need of care that detects irregularities […]
July 2, 2021
Virtual Walking helps to ease “phantom pains”
Canton Lucerne — The Centre for Pain Medicine and Lucerne University of Applied Sciences and Arts have together developed a globally unique installation to help paraplegics manage phantom pains. The aim is for Virtual Walking to ease the burden on an overworked brain. Researchers from the Lucerne University of Applied Sciences and Arts (HSLU) in […]
June 10, 2021
Cartilage Repair Breakthrough is now FDA approved for US Market
Geistlich Pharma, based in Lucerne, Switzerland, has been granted Breakthrough Device Designation for Chondro-Gide® by the US Food and Drug Administration (FDA). Chondro-Gide® is a collagen membrane that is used in a one-step cartilage repair technique. The FDA’s Breakthrough Devices Program was developed in order to expedite the pathway from development through to testing of […]
February 4, 2021
Monarch Bioimplants secures record investment at Technopark Lucerne
Monarch Bioimplants, a startup from Technopark Lucerne, is receiving 20 Million euro over the next 36 months from New York investment group GEM. The GEM Group with branches in New York, Los Angeles and Paris is making a major investment in Monarch Bioimplants. The U.S. investment group has agreed to provide Monarch Bioimplants with a […]
January 1, 2021
Virus-neutralizing UV Light to fight Infectious Disease
Technopark Lucerne – The medical and microtechnology start-up smolsys kills off viruses using ultraviolet (UV) light. The company’s innovative microtechnology components that are sealed in glass radiate 220 nanometers of UV-C light. Up until now, energy-guzzling mercury vapor lamps were required for this level of radiation power, for example to disinfect surgical instruments. The technology developed […]
January 1, 2021